This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Stock Reports for Apple, Mastercard & Eli Lilly
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Mastercard (MA) and Eli Lilly (LLY).
Anheuser-Busch Inbev (BUD) Upgraded to Buy: Here's Why
by Zacks Equity Research
Anheuser-Busch Inbev (BUD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AB InBev (BUD) Beats on Q2 Earnings & Sales as Markets Evolve
by Zacks Equity Research
AB InBev's (BUD) better-than-expected performance in second-quarter 2020 is attributed to a gradual improvement in volume as markets evolve despite the impacts of the pandemic.
Altria's (MO) Q2 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Altria's (MO) second-quarter 2020 results reflect adjusted OCI growth in oral tobacco and smokeable product segments. However, smokeable product revenues decline.
Things You Must Know Ahead of AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
Softness in the on-premise channel due to closure of restaurants and bars is expected to have marred AB InBev's (BUD) top line in Q2. E-commerce sales are likely to partly cushion results.
The Zacks Analyst Blog Highlights: Alphabet, Merck, Medtronic, Netflix and Anheuser-Busch InBev
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alphabet, Merck, Medtronic, Netflix and Anheuser-Busch InBev
The Market Timing Secrets No One Talks About - July 13, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Top Stock Reports for Alphabet, Merck & Medtronic
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), Merck (MRK) and Medtronic (MDT).
Why AB InBev (BUD) Stock Might be a Great Pick
by Zacks Equity Research
AB InBev (BUD) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Bull of the Day: The Boston Beer Company, Inc. (SAM)
by Benjamin Rains
Boston Beer is benefitting from a different drinking revolution these days: The explosion of hard seltzer...
Yes, You Can Time the Market. Find out How - June 19, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Top Analyst Reports for Procter & Gamble, Eli Lilly & Thermo Fisher
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Eli Lilly (LLY) and Thermo Fisher Scientific (TMO).
Implied Volatility Surging for AB InBev (BUD) Stock Options
by Zacks Equity Research
Investors need to pay close attention to AB InBev (BUD) stock based on the movements in the options market lately.
Top Stock Reports for Alibaba, UnitedHealth & Merck
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group (BABA), UnitedHealth (UNH) and Merck (MRK).
The Keys to Successfully Timing the Markets - May 28, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Jobless Claims on Downward Slope to 3.169M Last Week
by Mark Vickery
New initial claims registered 3.169 million, above the 3.10 million expected by analysts but beneath the previous week's 3.84 million.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
AB InBev (BUD) Posts Q1 Loss on Declines in On-Premise Volume
by Zacks Equity Research
AB InBev's (BUD) first-quarter 2020 results reflect a decline in volume due to the closure of the on-premise channel in most markets, owing to the coronavirus pandemic.
Factors to Decide the Fate of AB InBev (BUD) in Q1 Earnings
by Zacks Equity Research
AB InBev's (BUD) first-quarter 2020 results are expected to reflect significant impacts from manufacturing facility closures, social distancing and travel bans due to the coronavirus pandemic.
The Truth About Market Timing - May 05, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Altria's (MO) Q1 Earnings Top Estimates, Guidance Withdrawn
by Zacks Equity Research
Altria's (MO) first-quarter 2020 results reflect growth in oral tobacco products and smokeable segments. Management withdraws 2020 earnings guidance due to coronavirus.
Yes, You Can Time the Market. Find out How - April 14, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Diageo (DEO) Hurt by Coronavirus Impact, Withdraws FY20 View
by Zacks Equity Research
Diageo (DEO) withdraws FY20 view, cuts expenses and suspends share repurchase plan in the wake of the uncertain COVID-19 impacts. Also, its top line remains soft due to lockdown in many countries.
Buy Corona Maker Constellation (STZ) Stock Before Q4 Earnings Amid Surge?
by Benjamin Rains
Constellation Brands (STZ) shares have surged 40% in the last week. So now might be time for investors to consider buying the Corona beer maker's stock before it reports its Q4 fiscal 2020 results on Friday, April 3...
AB InBev Withdraws 2020 Guidance on Coronavirus Disruptions
by Zacks Equity Research
AB InBev (BUD) has withdrawn 2020 guidance, following the rising scale and magnitude of COVID-19, which led to shutdowns, social distancing, travel bans and other limitations in many countries.